Abstract |
In the last years the importance of the evaluation of antacid compounds according to their neutralizing capacity decreased. Clinical investigations have shown that antacid mixtures of aluminum-magnesium hydroxide healed gastric an duodenal ulcers (neutralizing capacity 100-150 mmol/day) as well as H2 receptor antagonists and better than a placebo. By this the necessary daily dosage could be reduced essentially. This paper presents studies showing that lattice like structured antacids (e.g. Magaldrate) healed gastric and duodenal ulcers (neutralizing capacity 100-350 mmol/day) as well as Ranitidine (150 mg b.d.). Maintenance therapy should be evaluated critically because sufficient data are not available and mineral metabolism is changed significantly by extremely small dosages of aluminium- magnesium hydroxide antacids even in patients with normal kidney function.
|
Authors | S E Miederer, C Schmidt |
Journal | Zeitschrift fur Gastroenterologie
(Z Gastroenterol)
Vol. 25 Suppl 3
Pg. 130-5
(Aug 1987)
ISSN: 0044-2771 [Print] Germany |
Vernacular Title | Gitterförmige Antazida und Antazidagemische. |
PMID | 3660893
(Publication Type: Comparative Study, English Abstract, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antacids
- Aluminum Hydroxide
- magaldrate
- Ranitidine
- Magnesium Hydroxide
|
Topics |
- Aluminum Hydroxide
(therapeutic use)
- Antacids
(therapeutic use)
- Drug Administration Schedule
- Duodenal Ulcer
(drug therapy)
- Gastric Acidity Determination
- Humans
- Magnesium Hydroxide
(therapeutic use)
- Peptic Ulcer
(drug therapy)
- Ranitidine
(therapeutic use)
- Recurrence
- Structure-Activity Relationship
- Wound Healing
(drug effects)
|